Read More

Vaxart Shares Positive Top-line Data From Mid-Stage Oral Pill COVID-19 Vaccine Study

Vaxart (NASDAQ: VXRT) announced positive top-line data from the first part of a planned two-part Phase 2 study of its Wuhan S-only oral pill COVID-19 vaccine candidate, VXA-CoV2-1.1-S. The top-line data readout exhibited that the trial met its primary safety and secondary immunogenicity endpoints.

VXRT

Read More

Want A Better Bang For Your Buck? Here Are 3 Dividend Stocks In The Discount Retail Sector

As high inflation forces the average consumer to prioritize necessities over wants, many shoppers are cutting back on discretionary spending. This can be attributed to the decrease in purchasing power due to higher consumer staples and energy bills, although people are purchasing fewer goods.

BIG